EMA Recommends Updating COVID-19 Vaccines for XFG Variant
The European Medicines Agency's (EMA) Emergency Task Force (ETF) has recommended updating COVID-19 vaccines to target the new SARS-CoV-2 variant XFG. This recommendation is for the upcoming 2026/2027 vaccination campaign. This development is crucial for public health, ensuring that available vaccines remain effective against evolving strains of the virus, and informs pharmaceutical companies and national health authorities on vaccine composition.
COVID-19 vaccines to be updated for new XFG variant for 2026/2027.